Bellerophon Provides Update on INOpulse Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements